Werewolf Therapeutics is a clinical-stage biotechnology company focused on developing novel cancer immunotherapies that harness engineered cytokines to stimulate the immune system against tumors, ...
WATERTOWN, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the “Company” or “Werewolf”), an innovative biopharmaceutical company pioneering the development of ...
Werewolf Therapeutics shares remain in focus as investors reassess valuation and cash runway following recent pipeline and collaboration updates. A look at the latest fundamentals, liquidity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results